1. Methylation status of the estrogen receptor 1 promoter predicts poor prognosis of acute-on-chronic hepatitis B liver failure
    Xiao-Peng Fan et al, 2017, Rev Esp Enferm Dig CrossRef
  2. Cisplatin Enhances Hepatitis B Virus Replication and PGC-1α Expression through Endoplasmic Reticulum Stress
    Xiaosong Li et al, 2018, Sci Rep CrossRef
  3. RFX1 participates in doxorubicin-induced hepatitis B virus reactivation
    Jie Wang et al, 2018, Cancer Med CrossRef
  4. Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System
    Akimasa Sanagawa et al, 2018, Cancer Med CrossRef
  5. MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models
    Kaifeng Wang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  6. Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection
    Soha Talima et al, 2018, Breast Cancer CrossRef
  7. Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo
    Qi Zhang et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  8. Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferation
    Bing Zheng et al, 2016, Sci Rep CrossRef
  9. null
    Qin Ning et al, 2019 CrossRef
  10. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
    Shiv Kumar Sarin et al, 2019, Hepatol Int CrossRef
  11. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014
    Shiv Kumar Sarin et al, 2014, Hepatol Int CrossRef
  12. New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts
    Valentina Svicher et al, 2019, Viruses CrossRef
  13. Hepatitis B and cancer: A practical guide for the oncologist
    Claudia Bozza et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
  14. Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma
    Qi-wen Chen et al, 2016, PLoS ONE CrossRef
  15. Hepatitis B virus reactivation after withdrawal of prophylactic antiviral therapy in patients with diffuse large B cell lymphoma
    Wei Ping Liu et al, 2016, Leukemia & Lymphoma CrossRef
  16. The effect of anticancer therapy on anti-hepatitis B antibody titres in patients with haematological malignancies and solid tumours
    Bahiddin Yilmaz et al, 2016, J Int Med Res CrossRef
  17. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment
    Xiao-Jun Lin et al, 2016, Dig Dis Sci CrossRef
  18. Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cells
    Yajuan Zhou et al, 2016, Biochemical and Biophysical Research Communications CrossRef
  19. Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
    C. S. Voican et al, 2016, Ann Oncol CrossRef
  20. Toxicities of different first-line chemotherapy regimens in the treatment of advanced ovarian cancer
    Chang-Ping Qu et al, 2017, Medicine CrossRef
  21. Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management
    Z. Liu et al, 2017, J Viral Hepat CrossRef
  22. Reactivation of Hepatitis B Virus and Its Prevention in Patients with Rheumatic Diseases Receiving Immunosuppressive Therapy
    Eun-Jung Park et al, 2017, J Rheum Dis CrossRef
  23. Regulation of Fas in response to bortezomib and epirubicin in colorectal cancer cells
    Ercan Cacan et al, 2020, Journal of Chemotherapy CrossRef
  24. A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer
    Xi-Ping Jiang et al, 2017, Oncotarget CrossRef
  25. The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent
    Zuquan Xiong et al, 2017, Oncotarget CrossRef
  26. Jujube leaf green tea extracts inhibits hepatocellular carcinoma cells by activating AMPK
    HX Liu et al, 2017, Oncotarget CrossRef
  27. Preclinical study of CC223 as a potential anti-ovarian cancer agent
    Zhenzhen Jin et al, 2017, Oncotarget CrossRef
  28. Cross-validation Studies of a Novel Low-cost Hepatitis B Virus Quantitative Polymerase Chain Reaction System
    Jorge Aguiar et al, 2018 CrossRef
  29. The Incidence and Predictive Factors in the Development of Acute Hepatitis in Patients with Leukemia
    Muhsin Kaya et al, 2018 CrossRef
  30. Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study
    Md. Arif Khan et al, 2021, Journal of Biomolecular Structure and Dynamics CrossRef
  31. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition?
    Jaciara Fernanda Gomes Gama et al, 2022, WJCC CrossRef
  32. Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition?
    Jaciara Fernanda Gomes Gama et al, 2022, WJCC CrossRef
  33. Epidemiology of liver failure in Asia‐Pacific region
    Ankur Jindal et al, 2022, Liver International CrossRef